Agios Pharma (AGIO) Tops Q2 EPS by 6c

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.31), $0.06 better than the analyst estimate of ($1.37). Revenue for the quarter came in at $37.35 million versus the consensus estimate of $37.71 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Kronos Worldwide (KRO) Tops Q2 EPS by 17c
• Cadre Holdings (CDRE) Misses Q2 EPS by 5c; Offers Guidance
• a.k.a. Brands Holding Corp. (AKA) Tops Q2 EPS by 22c; Offers Guidance